iTind
Reshaping BPH Treatment
iTind is a temporary implanted nitinol device. The minimally invasive iTind procedure delivers rapid and effective relief from BPH symptoms.
iTind is inserted in an efficient and straightforward procedure with a short learning curve. Through gentle pressure on the tissue and localized ischemia, the iTind procedure aims to reshape the tissue of the prostatic urethra and the bladder neck.
After 5-7 days, the iTind device is removed leaving nothing behind. The entire iTind procedure can be performed in the office environment under local anesthesia.
Why iTind?
Clinical data demonstrate that the first generation TIND boasts a durability of three years, and powerful efficacy at 6.6 years is also demonstrated by the second-generation and commercially available iTind 5 .
- Preserves sexual and ejaculatory function.
- Rapid and effective symptom relief.
- Routinely catheter free procedure.
- Lower risk profile than more invasive procedures.
- No Permanent Implant Resulting From the Procedure
The iTind Physician Training Program
The iTind Procedure Physician Training Pathway is designed to maximize your success when integrating the iTind procedure into your workflow and offer your patients a safe, minimally-invasive solution for rapid and effective relief of their BPH symptoms
Download training guide Find training opportunities
Physician Experience
"The iTind™ procedure is a perfect fit for patients that do not want to be on continued prescription BPH medication, do not want a permanent device implanted or are not yet ready for surgery."
Dr. Kenneth Kernen
St Clair Shores, M
Urologists used to keep patients as long as possible on BPH medications until surgery was an option for them but now the iTind™ procedure is a new minimally invasive treatment option.
Dr. Naveen Kella
The Urology Place, San Antonio, TX
"The iTind is a great new option for men looking for a minimally invasive therapy to manage their BPH symptoms. It’s straightforward and provides rapid symptom relief to patients, so it’s a win-win for the doctor and the patient."
Dr. Jonathan Warner
Emanate Health Foothill Presbyterian Hospital,CA
iTind Clinical Summaries 2022
More than 300 patients have been successfully treated with iTind in clinical studies. The iTind Clinical Summaries is a digestible, easy-to-use guide which provides overview of the latest clinical evidence relating to The iTind Procedure.
Read more
Clinical Evidence
- 1.3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction
- 2.3-Year results following treatment with the second generation of the temporary implantable nitinoldevice in men with LUTS secondary to benign prostatic obstruction
- 3.The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial.
- 4.Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study.
- 5.Long term follow-up of an international multicenter prospective study in application of temporary implantable nitinol device (iTind) in men with lower urinary tract symtomps for BPH
➝ Please click on the image to get a detailed view
iTind – Frequently Asked Questions
The iTind procedure is a new alternative to prescription medication or invasive surgery. If patients do not want to take a pill every day, or if they have tried standard drug treatments and were unsatisfied with the level of symptomatic relief or the way they made them feel. The iTind procedure might also be the right choice if patients are interested in preserving their sexual function and continence, are worried about having a permanent implant, or are concerned about undergoing a surgery that would involve a long recovery and downtime.
Most patients start to experience symptom relief shortly after the removal. Symptoms typically continue to improve over the following 6 to 12 weeks. In clinical studies there have been no indications of long-term adverse side effects. Since the iTind device is completely removed at the end of the treatment week, there is no risk of implant migration, encrustation, or tissue overgrowth. Moreover, there are no obstacles in maintaining a regular prostate screening program, including physical exams or any type of imaging, such as MRI, if needed.
The most common side effects experienced are the feeling of pressure in the area of the perineum, an increased frequency and urgency to urinate, light blood in urine, and slight burning upon urination. However, any side effects experienced typically subside shortly after the iTind device is removed. After insertion of the iTind device, patients may be kept for a few hours for observation. Upon returning home they may resume most normal activities depending on their personal level of comfort and their doctor’s advice.
Durability has been demonstrated in clinical studies out to 6.6 years in terms of symptom improvement, urinary flow and quality of life in a significant number of patients. The iTind procedure does not preclude retreatment or other BPH treatments, should they be needed or desired in the future. The iTind procedure leaves nothing behind. You can read more about the clinical data here.
Patient Information for iTind
If you have been diagnosed with an enlarged prostate due to BPH, there are many treatment options available. iTind is a clinically-proven, minimally-invasive treatment that relieves lower urinary tract symptoms due to an enlarged prostate, or BPH.
Learn more about iTind